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Abstract 
Background: Identification of bioactive standard chemicals is a major challenge in the study of the Chinese medici-
nal formula. In particular, the chemical components may interact differently depending on the preparative methods, 
therefore affecting the amounts of bioactive components and their pharmacological properties in the medicinal 
formula. With the use of Erxian decoction (EXD) as a study model—a  well-known Chinese medicinal formula for 
treating menopausal symptoms, a novel and rapid approach in seeking standard chemicals has been established by 
differentially comparing the HPLC profiles and the menopause-related biochemical parameters of combined decoc-
tion of EXD (EXD-C) and mixtures of the decoctions of its individual herbs (EXD-S).
Methods: The levels of six chemicals, which exerted actions on the HPO axis, have been measured in EXD-C and 
EXD-S by HPLC. Twelve-month-old female Sprague-Dawley rats were employed and treated with EXD-C and EXD-S. 
Their endocrine functions after treatment were evaluated by determining the ovarian mRNA levels of aromatase, a 
key enzyme for estradiol biosynthesis. The effect of the antioxidant regimen was determined by the hepatic superox-
ide dismutase-1 (SOD), catalase (CAT) and glutathione peroxidase (GPx-1) mRNA levels.
Results: The amounts of mangiferine, ferulic acid, jatrorrhizine and palmatine in EXD-S were twofold higher than 
those in EXD-C. EXD-S was more effective in stimulating ovarian aromatase and the expression of the antioxidant 
enzymes compared with EXD-C.
Conclusion: Mangiferine, ferulic acid, jatrorrhizine and palmatine are suitable for use as standard chemicals for qual-
ity evaluation of EXD according to our approach. EXD-S could be more effective than EXD-C.
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Background
The clinical use of Chinese medicine (CM) formulas for 
treating chronic diseases and aging-related disorders has 
been gaining momentum in recent years. The multiple 
pharmacological properties of CM formula are proved 
to be contributed by the multiple bioactive chemicals in 
a CM formula through multiple mechanisms [1]. Thus, 
seeking bioactive and standard chemical is crucial for 
quality control evaluation of CM formulas. While the 
contemporary analytic techniques allow us to isolate 
and detect multiples chemical components from CM 
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formulas simultaneously, identification of bioactive and 
standard chemicals remains a tedious task.
Due to the complexity of the chemicals in a CM for-
mula, the potential interaction and the subsequent 
changes in the pharmacological properties have drawn 
the attention of many researchers in the field [1]. Interac-
tions leading to changes in the chemical components of 
TCM may arise during the processing of herbal materials 
or during the decoction procedures [2]. Conventionally, 
different herbal materials in a Chinese medicinal formula 
are decocted together to yield the medicinal extract, 
which can be regarded as a “combined decoction”. To the 
contrary, individual herbs can be decocted separately and 
mixed together to compose a medicinal formula. This 
is particularly common in the recent development of 
herbal formulations, extracts of individual herbal mate-
rial can be concentrated in the form of granules, and the 
medicinal formula can be reconstituted by mixing the 
corresponding amounts of granules [3]. The resulting 
decoction is thus regarded as a mixture of decoctions of 
separated individual herbs (separated decoction)”. How-
ever, due to the difference in their decoction processes, 
there will be variations in the chemical components of 
the “combined decoction” and “separated decoction”. It 
is known that during the decoction process, the chemi-
cals from different herbs may interact to affect the solu-
bility, conversion of chemical structures, or may lead to 
generation of new chemicals or precipitation [3]. For 
example, results obtained from a previous study revealed 
that the component of 1,5-dicaffeoylquinic acid in the 
Tibetan herb (Saussurea laniceps) was transesterificated 
into 1,3-dicaffeoylquinic acid during boiling in water 
[4]. These interactions may affect the amounts of bioac-
tive components in the medicinal formula, and thus the 
pharmacological properties. On the one hand, the dis-
crepancy between the chemical components and the 
pharmacological properties between “combined decoc-
tion” and “separated decoction” has raised concerns 
about the variation in quality and therapeutic efficacy 
of decoctions prepared using different methods. On the 
other hand, such discrepancy may hint the bioactive 
components contributing to the pharmacological proper-
ties, thus opening up the possibility of a novel and rapid 
approach for identification of the chemical standards of 
CM formulas for quality control purpose.
In this study, Erxian decoction (EXD), an anti-meno-
pausal Chinese medicine formula, was selected as a study 
model to demonstrate the feasibility of our approach for 
identification of the chemical standards of CM formu-
las. Erxian decoction (EXD) is a popular TCM formula 
that has been clinically used for relieving menopausal 
syndrome for more than 60 years [5]. Our previous EXD 
studies have used a LC-DAD-ESI-MS/MS method in 
characterising the key chemical constitutents of EXD 
absorbed or metabolised in  vivo during the treatment 
of menopausal syndromes [6]. Knowing that the causes 
of menopausal syndromes involves the hypothalamus-
pituitary-ovary (HPO) axis, target compounds of this 
study were identified and differentiated by their presence 
in the major organs of the HPO axis (i.e. brain and ovary) 
and serum. Six chemicals from EXD that may contribute 
to relief of menopausal syndrome were selected: mangif-
erine, ferulic acid, icariin, jatrorrhizine, palmatine and 
berberine [6]. Therefore, the levels of mangiferine, feru-
lic acid, icariin, jatrorrhizine, palmatine and berberine in 
both EXD-C and EXD-S were determined and compared 
by HPLC profiles. Besides chemical analysis, it has been 
found in human that during menopause, the expression of 
aromatase, a key enzyme for ovarian estradiol production, 
and the activities of some antioxidant enzymes, including 
superoxide dismutase-1 (SOD1), and glutathione peroxi-
dase (GPx-1), underwent a decrease leading to a decline 
of ovarian estrogen production and serum estrogen level 
[7]. In addition, our previous study also demonstrated that 
EXD relieved menopausal syndrome via up-regulation of 
the mRNA levels of ovarian aromatase and hepatic anti-
oxidant enzymes catalase (CAT) in twelve-month-old 
naturally aging SD-rats with lower serum estradiol levels 
compared with those of 3-month-old young SD-rat [5]. 
Therefore, we evaluated and compared the pharmacologi-
cal properties of EXD-C and EXD-S for alleviating meno-
pause by measurement of their mRNA levels of ovarian 
aromatase and hepatic antioxidant enzymes SOD-1, CAT, 
and GPx-1 after drug treatment. Results and approach 
obtained from this study could be applied in quality con-
trol studies of other existing CM formulas, which ensure 
the use of high-quality CM formulas clinically. The follow-
ing shows our approach for selecting the standard markers 
for quality control of CM formulas: (i) the standard mark-
ers should be present at target sites/organs in vivo; (ii) the 
standard markers should be associated with pharmacolog-
ical and clinical effects of CM formulas; (iii) the amounts 
of standard markers should have twofold differences for 
different decoction processing (EXD-S: separate decoction 
of EXD vs EXD-C: combined decoction of EXD).
Methods
Herbal materials and preparation of different decoctions 
of EXD
One kilogram of the six component herbs of EXD namely 
Herba Epimedii, Rhizoma Curculiginis, Radix Morin-
dae officinalis, Cortex Phellodendri, Radix Anemar-
rhenae, and Radix Angelicae sinensis (composition 
ratio = 12:12:10:10:9:9) were decocted together with dis-
tilled water in 10:1 (v/w) ratio at 100 °C for 1 h to prepare 
“combined decoction of EXD” (EXD-C), the extraction 
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was repeated twice. The procedures were the same as those 
described in our previous publication [5]. For preparation 
of “mixtures of EXD individual herbs decoction” (EXD-S), 
the component herbs in the amounts according to above 
composition ratio of EXD-C were decocted separately 
instead and reconstituted afterward. The extraction was 
also repeated twice. Both of the herbal extracts, EXD-C 
and EXD-S, were filtered and lyophilized in a freeze drier 
(Labconco, Freezone). The dried powdered extracts were 
stored at −80  °C before use. The herbal materials were 
collected from various sources and their identity was con-
firmed by Dr YanBo Zhang (one of the authors), School of 
Chinese medicine, the University of Hong Kong.
Quality control and high performance liquid 
chromatography (HPLC)
To evaluate the consistency of the quality of EXD-S and 
EXD-C extracts, three batches of 0.5 g powder of extracts 
were extracted with 10  ml 75% methanol in a water 
bath at 60 °C for 15 min, followed by ultrasonication for 
30  min. The extracts were centrifuged at 15,700×g and 
filtered with 0.45  μm Millex® syringe filter (Millipore). 
Six standard chemicals namely mangiferine, ferulic acid, 
icariin, jatrorrhizine, palmatine and berberine which 
are well-known compounds in EXD [5] were employed 
for quantitation. The HPLC profiles of the EXD-S and 
EXD-C were generated using Water 600S HPLC system 
(Waters) with a reverse-phase column (XBridge® C18, 
5 μl, 250 mm × 4.6 mm i.d., Waters, USA). The mobile 
phase consisted of acetonitrile (solvent A) and 0.05% 
SDS in 0.1% acetic acid (solvent B). A programmed gra-
dient was used for elution with 5–30% A in 0–30  min, 
30% A in 30–35 min, 30–50% A in 35–40 min, 50–55% 
A in 40–65 min. The injection volume was 10 μl and flow 
rate was 1 ml/min. The ultraviolet (UV) absorbance from 
200 to 400  nm was measured with a  diode array detec-
tor (DAD). Chromatograms were generated at 345  nm 
to observed most number of peaks. The peak integra-
tion and quantitation were analyzed with the Waters 
Empower 2 software (Waters), the procedures were the 
same as those described in our previous publication [5].
Animals
Twelve-month old female Sprague-Dawley (SD)-rats 
with low serum estradiol levels were employed as the 
animal model [5]. Animals were purchased at the age of 
8 months from the Laboratory Animal Units, the Univer-
sity of Hong Kong and housed at an ambient tempera-
ture of 24 °C with a relative humidity of 50–65% and 12-h 
light–dark cycles till the required age. The rats were accli-
mated for four months and their serum estradiol levels 
were monitored before the experiment. The experiments 
had been approved by the Committee on the Use of Live 
Animals in Teaching and Research (CULATR) of the Li 
Ka Shing Faculty of Medicine, the University of Hong 
Kong.
Drug administration and organ harvesting
Rats were arbitrarily divided into six groups with ten ani-
mals each. EXD-S and EXD-C extracts dissolved in 2 ml 
of water (0.76 and 1.52 g/kg) were administered via gav-
age tubing daily for 6 weeks. The control group received 
an equal volume of water instead of drug. At the end of 
the experiment, the rats were euthanized by an intraperi-
toneal injection of pentobarbital (200  mg/kg). The ova-
ries and livers were collected and stored at −80 °C until 
further experiment.
RNA extraction and quantitative real‑time PCR
The RNA extraction and quantitative real-time PCR 
were performed according to the previous methods 
published by our group [5]. In brief, total RNA was 
isolated from the ovary and liver using the TRIZOL® 
reagent according to instructions of the manufacturer 
(Invitrogen Life Technologies). The purity and concen-
tration of RNA were determined by the absorbance at 
260/280  nm and at 260  nm, respectively. The cDNA 
was transcribed from 1 μg of total RNA using random 
hexamers (Promega) and reverse transcriptase II (Inv-
itrogen Life Technologies) following the manufacturer’s 
instructions. Quantitative real-time PCR was performed 
for the expression of aromatase (Cyp19), CAT, SOD-1, 
glutathione peroxidase 1 (GPx-1) genes and beta-actin 
(β-actin) as housekeeping control using the Platinum® 
quantitative PCR SuperMIX-UDG (Invitrogen Life 
Technologies) in a final reaction volume of 25  μl in 
0.25 X SYBR green (Molecular Probes®, Invitrogen Life 
Technologies) according to the manufacturer’s proto-
col. The sequences of the PCR primers are described in 
our previous study [5]. The target genes were amplified 
with the following programme: pre-incubation at 94 °C 
for 15 min, followed by 40 cycles of incubation at 94 °C 
for 20 s, 57 °C for 20 s and 72 °C for 20 s. Following the 
amplification process, a melting curve analysis was per-
formed by raising the temperature from 72 to 95  °C at 
a rate of 1 °C/5 s to ensure the specificity of PCR prod-
ucts. Quantitation of PCR product was performed by 
comparing with the standard curve (plot of number 
of threshold cycle (Ct) value against log of standard 
amount with a series of 20-fold dilution), and the results 
were expressed as Ct value. Quantity of the target genes 
was normalized with the housekeeping gene β-actin for 
relative quantitation. The experiments were repeated in 
triplicate for analysis.
Page 4 of 9Cheung et al. Chin Med  (2017) 12:1 
Statistical analysis
For the peaks in HPLC profiles of EXD-S and EXD-C, rel-
ative standard deviation (RSD) was calculated. For PCR 
experiments, data were expressed as mean ± SEM. Sta-
tistically analysis was performed using One-way ANOVA 
followed by Tukey’s Multiple Comparison Test. A p value 
<0.05 in a comparison was considered statistically signifi-
cant. Statistical analysis was performed with GraphPad 
Prism 4® software (GraphPad Software).
Results
HPLC profiles of EXD‑S and EXD‑C
The peaks from chromatograms generated at 345 nm show 
most detectable peaks were integrated. The chromato-
grams of EXD-S and EXD-C annotated with the six stand-
ard chemicals are shown in Fig. 1. Three batches of EXD-S 
and EXD-C were injected. The amounts of the six stand-
ard chemicals were determined from the standard curve 
and are listed in Table 1. The contents of all the six marker 
chemicals were found to decrease to different extents in 
EXD-C (Fig. 2). The content of mangiferin in EXD-S and 
EXD-C demonstrated a 2.09-fold difference. The decrease 
in content of three berberine-type alkaloids (jatrorrhizine, 
palmatine and berberine) in EXD-C varied from 3.44-old 
for jatrorrhizine, 30.17-fold for palmatine and 1.62-fold for 
berberine. The content of ferulic acid in EXD-C decreased 
by 2.46-fold and the amount of icariin showed a 1.17-fold 
decrease in EXD-C (Fig. 3). For all the six standard chemi-
cals, the RSD values calculated were within 5%, indicat-
ing consistency in the quality of the sample injected and 
reproducibility of the HPLC profile, as well as excluding 
the influence of any unknown variability or instability 
found in the composition of the active constituents in the 
molecular investigation of the EXD extract.   
Effects of EXD‑S and EXD‑C on expression of Cyp19, CAT, 
SOD and GPx‑1 at transcriptional level
After treatment with EXD-S and EXD-C for 6 weeks, the 
expression of ovarian Cyp19, SOD, CAT and hepatic GPx-1 
was regulated differently. From the results, both treatments 
with EXD-S and EXD-C at high doses significantly stimu-
lated the expression of ovarian Cyp19 gene, which encodes 
the key enzyme aromatase for estrogen secretion. (p < 0.01 
compared with control group in Tukey’s Multiple Com-
parison Test following One-way ANOVA). The stimulatory 
effect on up-regulation of Cyp19 was most prominent in 
EXD-S at high dose, which is in line with our previous find-
ing [5], in which the expression level of Cyp19 gene was sig-
nificantly higher than that of EXD-C at high dose (p < 0.001 
compared with control group in Tukey’s Multiple Compari-
son Test following One-way ANOVA) (Fig. 4).
The effects of EXD-S and EXD-C were less prominent 
on the gene expression of hepatic antioxidant enzymes. 
The relative mRNA levels of CAT after treatment of EXD 
were slightly higher than that of control by around 1.5-
fold, without statistical significance. EXD-S treatment 
at both dosages displayed a trend of increase in CAT 
expression compared with EXD-C, but again no signifi-
cant differences were detected (Fig. 5).
The mRNA levels of SOD-1 and GPx-1 in all treatment 
groups were comparable to that of control. However, 
in EXD-S (low dose) treated group, the hepatic mRNA 
expression of SOD-1 was significantly higher than that 
of EXD-C (low dose) group (Fig. 6). EXD-S at high dose 
also displayed a tendency of increase in the mRNA level 
of hepatic GPx-1 compared with that of EXD-C groups, 
but such tendency was devoid of statistically significant 
difference (Fig. 7). 
Discussion
The effects of different decoction methods on chemical 
profiles of anti-menopausal EXD formula have been dem-
onstrated by HPLC, with the six selected chemicals that 
have been present at HPO-axis in vivo revealed from our 
previous publication [6]. Results obtained from HPLC 
profile revealed that all the six chemicals including man-
giferin, ferulic acid, icariin, jatrorrhizine, palmatine and 
berberine were higher in content in EXD-S than that in 
EXD-C (Figs. 2, 3), the HPLC profile of EXD-S is the same 
as that in our previous publication [5]. Such changes in 
chemical profiles may be due to the interaction of different 
components during the decoction process. For instance, 
the chemical components may enhanced the solubility of 
each other when decocted together thus increasing the 
final content of chemicals in the extract [8]. On the con-
trary, they may precipitate with each other forming insolu-
ble complex leading to loss of bioactive components [8]. 
It is known that alkaloids like berberine, palmatine and 
jatrorrhizine would form precipitate with the flavone bai-
calin [9]. Alkaloids may also precipitate with organic acids 
forming insoluble salts [8]. It is possible that the alkaloids 
species in combined decoction of EXD (EXD-C) may 
precipitate with organic acid from its different ingredient 
herbs like ferulic acid, flavonoid compounds such as icariin 
or other undetected flavone species and are lost from 
EXD-C. Also, bioactive components can be converted 
by chemical reactions like hydrolysis of glycosides. In the 
combined decoction of EXD (EXD-C), hydrolysis may be 
facilitated to remove the sugar units from the flavonoids 
glycoside icariin, leading to decrease in its content [2].
Mangiferine, ferulic acid, jatrorrhizine and palmatine 
were confirmed as the key chemical markers for quality 
control of anti-menopausal EXD according to our pro-
posed approach. Because (i) they have been present at 
HPO axis, revealed by our previous study; (ii) their phar-
macological effects are related to menopause. As it has 
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been reported that along with aging and menopause, the 
antioxidant enzymes is down-regulated, and the estrogen 
secretion through aromatase is hampered [6]. These four 
chemical markers possess antioxidant activities [10–13]. 
Besides, ferulic acid were also reported to have estro-
genic properties, its treatment increases the bone mineral 
Fig. 1 Overlaid HPLC chromatograms of a EXD-S [4] and b EXD-C from three repeated injections extracted at 345 nm. The peaks of six standard 
chemicals were annotated as mangiferine, ferulic acid, icariin, jatrorrhizine, palmatine and berberine, in a chorological order of retention time
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density in ovariectomized female rats of the Sprague-
Dawley strain with slightly increasing the serum levels of 
estrogen [14]. In addition, it has been shown to be effec-
tive in treating hot flashes in menopausal women [15]; 
(iii) the amounts of these four chemical markers in EXD-S 
are twofold higher than those in EXD-C, thus different 
decoction methods could be easily revealed by different 
amounts of these four markers in HPLC profile (Fig. 3). In 
particular, palmatine is almost 30.38-fold higher in EXD-S 
compared with EXD-C (Fig. 3), which will be further bio-
logically characterized in our further experiment.
Besides chemical analysis, the effects of EXD-S and 
EXD-C on ovarian aromatase mRNA expression and 
hepatic antioxidant enzymes were evaluated, which has 
also been proven as the targets of EXD by our group pre-
viously [5]. As anticipated, EXD stimulated ovarian aro-
matase (Cyp19) expression the transcriptional level at 
high dose (1.76 g/kg). The up-regulation of Cyp19 mRNA 
level in EXD-S-treated rats was significantly almost two-
fold higher than that of EXD-C, which may have been 
due to the overall increase in bioactive components in 
EXD-S as revealed from the HPLC profiles. It is known 
that the bioactive components in EXD such as mangif-
erin, berberine, palmatine and jatrorrhizine possess anti-
oxidant activities [10–13]. Besides, icariin and ferulic 
acid were also reported to have estrogenic properties [14, 
16]. The lower amounts of these bioactive compounds in 
EXD-C may explain the decreased bioactivity of EXD-C 
Table 1 The contents of six standard chemicals of EXD in three injections of EXD-S and EXD-C
The results are expressed as mg or chemicals per g of EXD extract. RSD values were calculated for each chemical from three injections and the mean ratio represents 
the ratio of amount of chemicals in EXD-S to that of EXD-C
Injection Mangiferin (mg/g) Ferulic acid (mg/g) Icariin (mg/g) Jatrorrhizine (mg/g) Palmatine (mg/g) Berberine (mg/g)
EXD-S1 1.368 0.4871 1.731 0.1004 1.083 1.615
EXD-S2 1.371 0.4896 1.744 0.1010 1.090 1.617
EXD-S3 1.382 0.4996 1.745 0.1014 1.092 1.628
Mean 1.374 0.4921 1.740 0.1010 1.089 1.620
RSD (%) 0.57 1.34 0.46 0.48 0.46 0.43
EXD-C1 0.6581 0.1983 1.498 0.02865 0.03577 1.000
EXD-C2 0.6610 0.1980 1.493 0.03009 0.03661 1.001
EXD-C3 0.6583 0.2034 1.479 0.02947 0.03592 1.003
Mean 0.6591 0.1999 1.490 0.02940 0.03610 1.001
RSD (%) 0.24 1.53 0.65 2.45 1.23 0.17
Mean ratio 2.085 2.462 1.168 3.435 30.17 1.618
Fig. 2 The ratio of six standard markers in EXD-S and EXD-C
Fig. 3 The fold differences of standard markers in EXD-S/EXD-C
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in vivo. The effects of EXD-S on mRNA level of hepatic 
antioxidants are in line with our previous findings [5]. In 
our previous study, EXD could significantly up-regulate 
CAT expression at the transcriptional level [5]. In this 
study, both EXD-S and EXD-C elicited around 1.5-fold of 
increase in the mRNA level of CAT, although no statisti-
cal significance was detected. Consistent with the results 
of Cyp19 expression, EXD-S showed a stronger tendency 
of stimulation of CAT and GPx-1 than EXD-C. The 
mRNA level of SOD-1 in EXD-S-treated group was sig-
nificantly higher than that of the group treated with low 
dosages of EXD-C. These again support the better phar-
macological properties of EXD-S than EXD-C.
In a TCM formula, the complexity of chemical compo-
nents imposes difficulties in the identification of standard 
chemicals for quality control. The observation of differ-
ences in the chemical profiles of EXD-S and EXD-C in 
relation to their bioactivity has opened up the possibil-
ity of a novel and rapid approach to identify the standard 
chemicals in CM formulas. Since the pharmacological 
properties of a medicinal formula are conferred by the 
chemical components, which may change as a result of 
different decoction conditions. By comparing the HPLC 
profiles of the decoctions, the differentially extracted 
components would be those responsible for the observed 
discrepancy in bioactivity. This would facilitate the iden-
tification and selection of bioactive components as stand-
ard chemicals out of the complex herbal mixture. In a 
study on Radix Scutellariae (Huangqin) decoction, an 
increase in the amount of the bioactive compound bai-
calin was observed in the combined decoction [17]. In 
another study on Tangkuei Liu Huang Decoction, the 
amount of baicalin was higher   in separate decoctions 
than that of combined decoction [18]. These findings sug-
gest that the bioactive components in a herbal extract can 
be affected by the decoction method as well as the herbal 
interaction between different herbs. The decoction meth-
ods would also affect the pharmacological properties. 
In some studies, the combined decoction may have bet-
ter therapeutic efficacy and vice versa [19, 20]. Whether 
the component herbs of a Chinese medicinal formula 
should be decocted separately or in combination together 
depends on different individual formulas, but the decoc-
tion of herbal materials is often an inevitable process for 
the preparation of most of the CM prescriptions. The 
evaluation of chemical profiles as well as the pharmaco-
logical properties of different processing methods may 
indicate a novel approach for identifying the standard 
chemicals of the CM formula. In this study, the feasibility 
of such approach is evaluated by differential comparison 
Fig. 4 The relative expression of Cyp19 gene at transcriptional level 
in ovaries of SD-rats treated with different EXD decoctions. Data were 
normalized by control group and expressed as mean ± SEM. Control: 
control group (fed with water); EXD-S: SD-rats treated with separate 
decoction of EXD at 0.76 g/kg (low) and 1.52 g/kg (high); EXD-C: 
SD-rats treated with combined decoction of EXD at 0.76 g/kg (low) 
and 1.52 g/kg (high). ***p < 0.001 compared with Control;###p < 0.001 
compared with EXD-C (low);+++p < 0.001 compared with EXD-C 
(high) (Tukey’s Multiple Comparison Test following One-way ANOVA) 
(n = 3)
Fig. 5 The relative expression of CAT gene at transcriptional level 
in livers of SD-rats treated with different EXD decoctions. Data were 
normalized by control group and expressed as mean ± SEM. Control: 
control group (fed with water); EXD-S: SD-rats treated with separate 
decoction of EXD at 0.76 g/kg (low) and 1.52 g/kg (high); EXD-C: 
SD-rats treated with combined decoction of EXD at 0.76 g/kg (low) 
and 1.52 g/kg (high). No statistical significances were detected 
among groups (Tukey’s Multiple Comparison Test following One-way 
ANOVA) (n = 3)
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of the HPLC profile of EXD-S and EXD-C in relation to 
the pharmacological properties. Eventually, this approach 
can be coupled with analytic techniques to identify the 
differentially extracted components obtained by different 
decoction methods.
In future developments, such approach may be pol-
ished by further validations with a more comprehensive 
pharmacological screening platform, and further evalua-
tion of the feasibility of this approach can be conducted 
with other Chinese medicinal formulas. The four key 
chemicals, including mangiferine, ferulic acid, jatror-
rhizine and palmatine, found in EXD could be further 
investigated in  vitro and in  vitro to identify their com-
bined effects as a mixture of four in treating menopausal 
syndromes.
Conclusions
In this study, the HPLC profiles of EXD-S and EXD-C 
have been evaluated with six known marker chemicals, 
which exerted actions on the HPO axis. All six chemicals 
were present at a higher level in EXD-S than in EXD-C. 
Four of them, including mangiferine, ferulic acid, jatror-
rhizine and palmatine, were demonstrated to be suitable 
standard chemicals for quality control of EXD according 
to our novel and rapid approach. Both EXD-S and 
EXD-C displayed stimulatory effects on the expression of 
ovarian aromatase and hepatic SOD-1, with the effect of 
EXD-S being more potent. The changes of pharmacologi-
cal activity in relation to the changes in chemical profiles 
of EXD decoction demonstrated the feasibility of a novel 
and rapid approach for identification of bioactive stand-
ard compounds from TCM formulas.
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